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ABSTRACT 
 
 
The rational design of effective and safe non-viral gene vectors is largely dependent on 
the understanding of the structure-property relationship. This thesis aims to report the design of a 
new series of cationic, α-helical polypeptides with different side charged groups (amine and 
guanidine) and hydrophobicity, and to mechanistically unravel the effect of polypeptide structure 
on the gene delivery capability. Guanidine-containing polypeptides displayed superior membrane 
activities to their amine-containing analogues via the pore formation mechanism, and thus 
possessed notably higher transfection efficiencies. Elongating the hydrophobic side chain also 
potentiated the membrane activities of the polypeptides, while at the meantime caused higher 
cytotoxicities. Upon an optimal balance between membrane activity and cytotoxicity, maximal 
transfection efficiency was achieved which outperformed commercial reagent LipofectamineTM 
2000 (LPF2000) by 3-6 folds. This study thus provides mechanistic insights into the rational 
design of non-viral gene delivery vectors, and the top-performing materials identified also serve 
as promising additions to the existing systems. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Thanks to advanced knowledge in molecular biology and genetic engineering, many 
disease-associated genes and their molecular regulators which provide potential targets for 
disease treatment have been successfully identified. Gene therapy, mediated by the transfer of 
genetic materials into target cells or tissues to promote or rectify the expression of specific genes, 
becomes a promising approach to treat human disease such as cancer, cystic fibrosis, arthritis, 
Gaucher disease and so on [1-3]. Due to the impermeability of genetic materials to cell 
membranes, the development of efficient yet biocompatible delivery vectors is crucial in the 
applications of gene therapy. Viral vectors have been long investigated and dominated current 
clinical trials [4, 5]. Despite their high efficiency, viral vectors present severe safety concerns 
such as carcinogenicity, immunogenicity and insertional mutagenesis [6]. Non-viral vectors, 
mostly cationic liposomes and polymers, possess desired biocompatibility and minimal 
mutagenesis and thus serve as alternatives to viral vectors for gene delivery [7-9]. 
Cell penetrating peptides (CPPs), exemplified by HIV-TAT, penetratin, transportan and 
Arg9, are sequence-specific oligopeptides that possess excellent membrane activities. It has been 
reported that CPPs often adopt inherent helical conformations or form helices during membrane 
transduction. Mechanistic simulation also suggests that the formation of a trans-membrane helix 
presents a rigid amphiphilic structure to stabilize the membrane interactions and promote the 
membrane permeability [10-15]. Due to their distinguished membrane permeability, CPPs are 
able to mediate the delivery of various cargos such as nucleic acids, proteins, peptides and even 
2 
 
nanoparticles. However, when utilized as gene delivery vectors, CPPs are often too short (fewer 
than 25 amino acid residues) and lack adequate cationic charge density. Hence, they are usually 
unable to function as stand-alone vectors to independently condense and subsequently deliver 
genes. Instead, they were incorporated or conjugated to existing delivery vectors as component 
material that could facilitate the cellular internalization and endosomal escape of the gene cargo 
[16-19]. Comparatively, polypeptides such as poly-L-lysine (PLL) and poly-L-arginine (PLR), 
were among the first set of materials adopted as non-viral vectors [20-22]. Although they are 
able to independently condense and deliver plasmid DNA due to the sufficient backbone length, 
they suffered from generally low transfection efficiency [23]. This is largely attributed to the fact 
that they adopt random coil conformation in the aqueous solution or when associated with 
phospholipid membranes because of the strong side chain charge repulsion, which hence 
severely comprised the membrane activities of these polypeptides with high molecular weight 
(MW) [13].  
In order to address the disadvantages of both short CPPs and polypeptides towards gene 
delivery, we recently developed a strategy to stabilize the helical secondary conformation by 
positioning the side charged groups distally from the polypeptide backbone, such that the side-
chain repulsion could be diminished and the helical structure could thus be stabilized [24]. A 
library of cationic polypeptides containing various amine side groups was thus synthesized and 
screened for their gene delivery capacities [25]. The top-performing material named PVBLG-8 
was identified and thus exploited as an effective delivery vehicle of gene cargo, wherein its 
polymeric nature achieved the condensation of DNA and the stable helical structure contributed 
to its cell penetrating capability, notably outperforming traditional CPPs and polypeptides [26, 
27]. Although such screening process allows the identification of desired materials, rational 
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design over polymer structure and mechanistic studies on the structure-function relationship 
would be more efficient and promising to further maximize gene transfection efficiency [28, 29]. 
Arginine (Arg) residues are often found rich in CPPs’ primary structures, and the 
guanidine groups of the Arg residues have been closely tied to the functionalities of CPPs 
because of their interaction with the sulfate groups of glycosaminoglycans on cell membranes 
[30]. In addition, hydrophobicity also has significant effects on cell penetrating efficiency. Tew 
and et al. demonstrated that the incorporation of hydrophobic residues into CPPs or CPP mimics 
enhanced cell penetration property, termed a “self-activation” manner [31, 32]. Motivated by 
these understandings, we herein report the design of a new series of cationic, α-helical 
polypeptides with different side charged groups (amine and guanidine) and hydrophobicity, 
attempting to illuminate the effect of polymer structure and functionality on the gene transfection 
efficiency. We hypothesized that the incorporation of helical structures, guanidine groups and 
elongated hydrophobic side chains would endow the polypeptides with considerable advantages 
associated with gene delivery over conventional CPPs and polypeptides, and an optimal 
combination would thus lead to the maximization of the gene delivery capabilities of cationic 
helical polypeptides. Alkyne-functionalized N-carboxylanhydride (NCA) monomers were first 
polymerized via a controlled ring-opening polymerization method [33] and post-modified 
through “click” chemistry. Those two well-controlled and efficient chemistries rendered the 
resulting polypeptides with narrow molecular weight distributions (MWDs) and precise 
structures, presenting an ideal template for such studies on structure-function relationship. In two 
different mammalian cell lines (HeLa and COS-7), polypeptides with diverse structures were 
comprehensively studied in terms of their membrane activities, intracellular DNA delivery 
efficiencies, intracellular kinetics, transfection efficiencies and cytotoxicities. This fundamental 
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study hence provides insights into the rational design of non-viral gene delivery vectors and 
strategy to maximize gene transfection efficiency. 
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CHAPTER 2 
 
 
EXPERIMENTAL 
 
 
2.1. Materials and cell lines 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) and used as 
received unless otherwise indicated. Anhydrous tetrahydrofuran (THF), hexane, and 
dimethylformamide (DMF) were dried by a column packed with 4Å molecular sieves and stored 
in a glovebox. Hexamethyldisilazane (HMDS) was dissolved in DMF in a glovebox and 
subsequently used to initiate the controlled ring-opening polymerization (ROP) of N-
carboxyanhydride (NCA). Plasmid DNA encoding luciferase (pCMV-Luc) was purchased from 
Elim Biopharmaceutics (Hayward, CA, USA). YOYO-1, LipofectamineTM 2000 (LPF2000), and 
3-(4,5-dimethylthiahiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) were purchased 
from Invitrogen (Carlsbad, CA, USA).  
HeLa (human cervix adenocarcinoma) and COS-7 (African Green Monkey SV40-transf'd 
kidney fibroblast) were purchased from the American Type Culture Collection (Rockville, MD, 
USA) and were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Grand Island, 
NY, USA) containing 10% fetal bovine serum (FBS). 
 
2.2. Instrumentation 
1H NMR spectra were recorded on a Varian U500 MHz or a VXR-500 MHz spectrometer. 
Gel permeation chromatography (GPC) experiments were conducted on a system equipped with 
an isocratic pump (Model 1100, Agilent Technology, Santa Clara, CA, USA), a DAWN 
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HELEOS multi-angle laser light scattering (MALLS) detector (Wyatt Technology, Santa 
Barbara, CA, USA), and an Optilab rEX refractive index detector (Wyatt Technology, Santa 
Barbara, CA, USA). The detection wavelength of HELEOS was set at 658 nm. Separations were 
performed using serially connected size exclusion columns (100 Å, 500 Å, 103Å and 104 Å 
Phenogel columns, 5 µm, 300 × 7.8 mm, Phenomenex, Torrance, CA, USA) at 60 °C using DMF 
containing 0.1 M LiBr as the mobile phase. The MALLS detector was calibrated using pure 
toluene and can be used for the determination of the absolute molecular weights (MWs). The 
MWs were determined based on the dn/dc value of each polymer sample calculated offline by 
using the internal calibration system processed by the ASTRA V software (version 5.1.7.3, 
Wyatt Technology, Santa Barbara, CA, USA). Circular dichroism (CD) experiments were 
performed on a JASCO J-815 CD spectrometer. Polypeptides were dissolved in deionized (DI) 
water at the concentrations of 0.025-0.2 mg/mL unless otherwise indicated. The solution was 
placed in a quartz cell with a light path of 1 or 10 mm. The mean residue molar ellipticity of each 
polypeptide was calculated based on the measured apparent ellipticity by following equations 
reported in literature: Ellipticity ([θ] in deg·cm2·dmol-1) = (millidegrees × mean residue 
weight)/(pathlength in millimeters × concentration of polypeptide in mg mL-1). The helicity of 
the polypeptides were calculated by the following formula: helicity = (-[θ222] + 3000)/39000 [34]. 
In order to examine the helical stability of the polypeptides against pH, the pH of the polypeptide 
solution was accordingly adjusted with 1 M NaOH or 1 M HCl. The polypeptide concentration 
was fixed at 0.1 mg/mL for the pH and salt-dependent analyses.  
 
2.3. Synthesis of the γ-(4-propargyloxybenzyl)-L-glutamic acid N-carboxyanhydride (POB-L-Glu-
NCA) monomer 
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K2CO3 (15.2 g, 0.11 mol) and 4-hydroxybenzyl alcohol (9.3 g, 0.075 mol) were 
suspended in acetone (150 mL) into which propargyl bromide solution (80 wt% in toluene, 10 
mL, 0.09 mol) and 18-crown-6 (0.1 mL) were added. The reaction mixture was refluxed at 75 oC 
for 12 h before removal of acetone by evaporation. Water (200 mL) was then added to the 
residue, and the aqueous layer was extracted with CH2Cl2 (DCM) (3 × 30 mL). The organic 
solutions were combined, washed with 15% NaOH solution (200 mL) and water (200 mL), and 
dried over Na2SO4. The product propargyloxybenzyl alcohol was obtained by removal of the 
solvent to yield clear yellow oil (9.7 g, yield 80%). 1H NMR (CDCl3): δ 7.28 (d, 2H, ArH), 6.94 
(d, 2H, ArH), 4.67 (d, 2H, ArCH2-), 4.60 (s, 2H, CH2O-), 2.50 (t, 1H, HC≡C-). 
The obtained propargyloxybenzyl alcohol (8.5 g, 52 mmol) was dissolved in DCM on an 
ice bath, and thionyl chloride (5 mL, 68 mmol) was added dropwise into the solution. The 
mixture was stirred at room temperature with the protection of nitrogen for 3.5 h, and water (100 
mL) was then added to quench thionyl chloride. The organic layer was washed with water (3 × 
50 mL) and dried over MgSO4. The product propargyloxybenzyl chloride was obtained by 
removal of the solvent to yield clear yellow oil (7.0 g, yield 75%). 1H NMR (CDCl3): δ 7.31 (d, 
2H, ArH), 6.94 (d, 2H, ArH), 4.68 (d, 2H, ArCH2-), 4.55 (s, 2H, CH2O-), 2.51 (t, 1H, HC≡C-). 
L-Glutamic acid copper (II) complex (3.29 g, 6.7 mmol) and L-glutamic acid (1.99 g, 13.4 
mmol) were suspended in a mixture of DMF (12 mL) and water (2 mL) into which 1,1,3,3-
tetramethylguanidine (3.4 mL, 27 mmol) was added. The mixture was stirred at 40 oC for 2 h 
until all compounds were dissolved. DMF (10 mL) and the obtained propargyloxybenzyl 
chloride (6.5 g, 36 mmol) were added to the solution which was stirred at room temperature for 
48 h. Acetone (200 mL) was then added, and the mixture was stirred overnight. The crude 
product was isolated and washed with acetone (4 times) and water (3 times), and 
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ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) solution (0.45 M) twice. The product 
γ-(4-propargyloxybenzyl)-L-glutamic acid (POB-L-Glu) was obtained via recrystallization from 
isopropanol/water (2:1, v/v) (3.2 g, yield 80%). 1H NMR (DMSO-d6/DCl-D2O (20 wt %), 9:1, 
v/v): δ 7.30 (d, 2H, ArH), 6.96 (d, 2H, ArH), 5.00 (s, 2H, ArCH2-), 4.77 (d, 2H, ArOCH2-), 3.91 
(m, 1H, α-H), 3.55 (t, 1H, HC≡C-), 2.54 (m, 2H, -CH2CH2COO-), 2.04 (m, 2H, -CH2CH2COO-
). 
POB-L-Glu (1.15 g, 4.0 mmol) was dissolved in dry THF (25 mL) followed by addition 
of the phosgene solution (15 wt% in toluene, 4.0 mL, 5.6 mmol). The mixture was refluxed at 
50 °C for 2 h. The solvent was removed under vacuum, and the crude product was recrystallized 
three times (THF/hexane, 1:5, v/v) to give γ-(4-propargyloxybenzyl)-L-glutamic acid N-
carboxyanhydride (POB-L-Glu-NCA) as white crystals (770 mg, yield 61%). 
1H NMR (CDCl3): 
δ 7.29 (d, 2H, ArH), 6.98 (d, 2H, ArH), 6.3 (s, 1H, NH), 5.08 (s, 2H, ArCH2-), 4.70 (d, 2H, 
ArOCH2-), 4.36 (t, 1H, α-H), 2.55 (m, 3H, -COCH2CH2-, HC≡ C-), 2.04 (m, 2H, -
CH2CH2COO-), 2.29-2.10 (m, 2H, -CH2CH2COO-). 
 
2.4. Polypeptide synthesis 
2.4.1. Polymerization of poly(γ-(4-propargyloxybenzyl)-L-glutamate) (PPOBLG) 
In a glovebox, POB-L-Glu-NCA (100 mg, 0.32 mmol) was dissolved in DMF (1.5 mL), 
followed by the addition of the HMDS solution (64 μL, 0.1 mol/L, M/I = 50). The mixture was 
stirred at room temperature for 48 h (monomer conversion > 99% as monitored by FTIR), and 
most DMF was removed under vacuum. The final product PPOBLG was precipitated with cold 
methanol and collected as white solid. 1H NMR (CDCl3): δ 7.20 (d, 2H, ArH), 6.86 (d, 2H, ArH), 
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5.00-4.93 (d, 2H, ArCH2-), 4.58 (s, 2H, ArOCH2-), 3.98 (s, 1H, α-H), 2.62-2.49 (br, 3H, -
CH2CH2COO-, HC≡C-), 2.29-2.12 (br, 2H, -CH2CH2COO-). 
 
2.4.2. Synthesis of azido amines/guanidines 
To obtain 3-azidopropylamine, sodium azide (5.85 g, 90 mmol) was added to a solution 
of 3-chloropropylamine hydrochloride (5.22 g, 45 mmol) in water (50 mL), and the mixture was 
heated at 80 °C for 24h. The pH was adjusted to 12 using 1 M NaOH, and the solution was 
extracted with diethyl ether (3 ×15 mL). The organic layer was dried over Na2SO4 and the 
solvent was removed under vacuum to obtain colorless oil (1.0 g, yield 30%). 1H NMR (CDCl3): 
δ 3.28 (t, 2H, -CH2N3), 2.71 (t, 2H, -CH2NH2), 1.61 (m, 2H, -CH2CH2N3). 
To obtain N,N-dimethyl-3-azidopropylamine, sodium azide (1.3 g, 20 mmol) was added 
to an aqueous solution of 3-dimethylamino-1-propyl chloride (1.58 g, 10 mmol, 20 mL), and the 
mixture was stirred at 70 °C for 12 h. KOH (5.0 g) was then added, and the aqueous solution was 
extracted with ether (3 × 15 mL). The combined organic phases was dried over Na2SO4 and 
concentrated to give colorless oil (0.98 g, yield 77%). 1H NMR (CDCl3): δ 3.34 (t, 2H, -CH2N3), 
2.35 (t, 2H, -CH2N(CH3)2), 2.25 (s, 6H, -N(CH3)2), 1.75 (m, 2H, -CH2CH2N3). 
To obtain 3-azidopropylguanidine, azidopropylamine (1.0 g, 10 mmol), H-pyrazole-1-
carboxamidine hydrochloride (1.47 g, 10 mmol), and DIEA (1.74 mL, 10 mmol) were dissolved 
in dry DMF (15 mL) which was stirred at room temperature overnight. Ether (150 mL) was 
added to precipitate the crude product which was collected, washed with ether, and dried under 
vacuum to obtain yellow liquid (1.0 g, yield 60%). 1H NMR (CDCl3): δ 3.33 (t, 2H, -
CH2NHC(NH)NH2), 3.18 (t, 2H, -CH2N3), 1.76 (m, 2H, -CH2CH2N3).  
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The synthesis of 6-azidohexylguanidine was carried out using the same method with 6-
azidohexylamine as the starting material. 1H NMR (CDCl3): δ 3.35 (t, 2H, -CH2NHC(NH)NH2), 
3.20 (t, 2H, -CH2N3), 1.77 (m, 2H, -CH2CH2NHC(NH)NH2), 1.67 (m, 2H, -CH2CH2N3), 1.32 (m, 
4H, -(CH2)2(CH2)2N3). 
The synthesis of 8-azidooctylguanidine was carried out using the same method with 8-
azidooctylamine as the starting material. 1H NMR (CDCl3): δ 3.35 (t, 2H, -CH2NHC(NH)NH2), 
3.20 (t, 2H, -CH2N3), 1.79 (m, 2H, -CH2CH2NHC(NH)NH2), 1.70 (m, 2H, -CH2CH2N3), 1.53-
1.02 (m, 8H, -(CH2)4(CH2)2N3). 
 
2.4.3. Synthesis of amine/guanidine functionalized polypeptides 
In a glovebox, PPOBLG (20 mg, 0.072 mmol alkyne groups) was dissolved in DMF (1.0 
mL) into which various azido amines/guanidines (0.144 mmol) and N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDETA, 30 μL, 0.144 mmol) were added. CuBr (20.8 mg, 
0.144 mmol) was then added, and the reaction mixture was stirred at room temperature for 24 h 
before addition of 1M HCl (1 mL). The final polypeptides were purified by dialysis against water 
for 3 days (MWCO = 3 kDa) and obtained after lyophilization. The nomenclature of 
polypeptides was summarized in Table 1. 
 
2.5. Polyplex formation and characterization 
Polypeptide and pCMV-Luc were separately dissolved in water at 0.2 mg/mL and mixed 
at various nitrogen/phosphate (N/P) ratios. The mixture was vortexed for 5 s and incubated at 
37 °C for 30 min to allow polyplex formation. The resultant polyplexes were subject to 
electrophoresis in 1% agarose gel at 100 V for 45 min to qualitatively evaluate DNA 
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condensation by the polypeptides. To quantitatively monitor the DNA condensation level, the 
ethidium bromide (EB) exclusion assay [35] was conducted. Basically, EB solution was mixed 
with DNA at the DNA/EB ratio of 10:1 (w/w) and incubated at room temperature for 1 h. 
Polypeptide was then added to the mixture at various N/P ratios, and the mixture was further 
incubated at room temperature for 30 min before quantification of the fluorescence intensity on a 
microplate reader (λex = 510 nm, λem = 590 nm). A pure EB exclusion and the DNA/EB solution 
without any polypeptide were used as negative and positive controls, respectively. The EB 
exclusion efficiency (% DNA condensed) was defined as the following: 
100)1((%) efficiency exclusion EB
0




EB
EB
FF
FF
 
Where FEB, F, and F0 denote the fluorescence intensity of pure EB solution, DNA/EB solution 
with polypeptide, and DNA/EB solution without any polypeptide, respectively. 
Particle size and zeta potential of polyplexes freshly prepared either in DI water or 
phosphate buffered saline (PBS) were further evaluated by dynamic laser scattering (DLS) on a 
Malvern Zetasizer (Herrenberg, Germany). To evaluate their stability against dilution, 
polyplexes were diluted with PBS for 50 folds, incubated at room temperature for different time, 
and subjected to particle size measurement.  
 
2.6. In vitro gene transfection 
Cells were seeded on 96-well plates at 1×104 cells/well and cultured in serum-containing 
DMEM medium for 24 h. The medium was then replaced by opti-MEM (100 μL/well), into 
which polyplexes were added at 0.1 μg DNA/well. After incubation at 37 oC for 4 h, the medium 
was replaced by serum-containing DMEM and cells were further incubated for another 20 h. 
Luciferase expression was assayed in terms of luminescence intensity using a Bright-Glo 
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luciferase assay kit (Promega, Madison, WI, USA), and the cellular protein level was determined 
using a BCA kit (Pierce, Rockford, IL, USA). Results were expressed as relative luminescence 
unit (RLU) associated with 1 mg of cellular protein (RLU/mg protein). In order to evaluate the 
transfection efficiency of polyplexes in the presence of serum, cells were incubated with 
polyplexes in DMEM supplemented with 10% FBS for 4 h. To further probe the temperature-
dependent transfection capabilities, cells were incubated with polyplexes in opti-MEM at 4 oC 
for a 4-h uptake period before further incubation at 37 oC for 20 h. LPF2000 was used as a 
control according to the manufacture’s protocol in all above-mentioned studies.  
 
2.7. Membrane activity 
The membrane activity of the polypeptides was evaluated by measuring the cellular 
uptake level of a membrane-impermeable dye, fluorescein isothiocyanate (FITC) in its non-
reactive form (fluorescein-tris(hydroxymethyl)methanethiourea, FITC-Tris) [36]. Cells were 
seeded on 96-well plates at 1×104 cells/well and cultured for 24 h. The medium was replaced by 
opti-MEM (100 μL/well), into which FITC-Tris and the polypeptide were added at 1 μg/well and 
2 μg/well, respectively. After incubation at 37 °C for 2 h, cells were washed with PBS containing 
heparin (20 U/mL) for three times and then lysed with the RIPA lysis buffer (100 μL/well). The 
amount of FITC-Tris in the cell lysate was quantified by spectrofluorimetry (λex = 488 nm, λem = 
530 nm), and the protein content was determined by the BCA kit. The uptake level was 
represented as ng FITC associated with 1 mg of cellular protein (ng FITC/mg protein). Cells 
incubated with free FITC-Tris in the absence of polypeptides were included as a negative control. 
Commercial CPPs, such as HIV-TAT, Arg9, and poly-L-arginine (PLR) were used as internal 
controls.  
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2.8. Intracellular kinetics 
DNA (1 mg/mL) was labeled with YOYO-1 (20 μM) at one dye molecule per 50 bp 
DNA in order to allow the quantification of the cellular uptake level [37]. YOYO-1-DNA was 
then allowed to form polyplexes with polypeptides at various N/P ratios as described above. 
Cells were seeded on 96-well plates at 1×104 cells/well and cultured for 24 h. The medium was 
replaced by opti-MEM followed by addition of the polyplexes at 0.1 μg YOYO-1-DNA/well. 
After incubation at 37 °C for 4 h, cells were washed with PBS containing heparin (20 U/mL) for 
four times to remove membrane-bound polyplexes, and were subsequently lysed with the RIPA 
lysis buffer (100 μL/well). YOYO-1-DNA content in the lysate was quantified by 
spectrofluorimetry (λex = 485 nm, λem = 530 nm), and the protein content was determined using 
the BCA kit. Cellular uptake level was expressed as ng YOYO-1-DNA associated with 1 mg of 
cellular protein (ng YOYO-1-DNA/mg protein). 
To probe the internalization mechanism of the polyplexes, the cellular uptake study was 
also performed at 4 °C or in the presence of various endocytic inhibitors. Briefly, cells were 
incubated with polyplexes (N/P = 10) at 4 °C for 2 h wherein the energy-dependent endocytosis 
was blocked. Otherwise, cells were incubated with various endocytic inhibitors including 
chlorpromazine (10 μg/mL), methyl-β-cyclodextrin (mβCD, 5 mM) and wortmannin (10 μg/mL) 
for 30 min prior to the addition of the polyplexes and throughout the 2-h uptake study. Results 
were represented as percentage uptake level of control cells that were incubated with the 
polyplexes in the absence of inhibitors at 37 °C for 2 h. 
The cellular internalization and distribution of polyplexes were further visualized by 
confocal laser scanning microscopy (CLSM, LSM 700, Zeiss, Germany). HeLa cells were 
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seeded on the coverslip in 6-well plate at 1×105 cells/well and cultured for 24 h. The medium 
was replaced with opti-MEM (1.5 mL/well), and polypeptide/YOYO-1-DNA polyplexes (N/P = 
10) were added at 1 μg YOYO-1-DNA/well before incubation at 37 °C for 4 h. Cells were then 
washed with heparin-PBS for four times, fixed with 4% paraformaldehyde (PFA), stained with 
DAPI (2 μg/mL) and Lysotracker®-Red (200 nM) before CLSM observation.  
 
2.9. Cytotoxicity 
Cells were seeded on 96-well plates at 1×104 cells/well and cultured for 24 h. The 
medium was replaced by opti-MEM (100 μL/well) into which polyplexes (N/P = 10) were added 
at 0.1, 0.2, 0.4, 1 and 2 μg DNA/well. After incubation at 37 oC for 4 h, the medium was 
replaced by serum-containing DMEM and cells were further incubated for another 20 h in 
consistence with the transfection process. Cell viability was then evaluated by the MTT assay. 
Cells without polyplex treatment served as the control and results were represented as percentage 
viability of control cells. 
 
2.10. Statistical analysis 
Statistical analysis was performed using Student’s t-test and differences between test and control 
groups were judged to be significant at *p < 0.05 and very significant at **p < 0.01. 
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CHAPTER 3 
 
 
RESULTS 
 
 
3.1. Synthesis and characterization of the polypeptides. 
PPOBLG was polymerized via ROP of POB-L-Glu-NCA mediated by HMDS, followed 
by the side-chain modifications through the azide-alkyne Huisgen cycloaddition, the well-known 
“click” chemistry [38]. HMDS-mediated polymerization allowed a controlled ROP, yielding 
well-defined polypeptide with narrow MWDs (~1.05) and desired degree of polymerization (DP 
= 49 at the monomer/initiator ratio of 50) as evidenced by the GPC traces (Figure 4). Due to the 
high efficiency of the “click” chemistry, the conjugation efficiency of amine- or guanidine-
containing side chains reached over 90% based on 1H NMR spectra (Figure 7-13). All the 
polypeptides were soluble in aqueous solutions at pH < 9, and adopted typical α-helical 
conformations as determined by the characteristic double-minima ellipticity at 208 and 222 nm 
in the CD spectra, distinctively different from the spectrum of poly(arginine) that adopts random 
coil conformation (Figure 14A, 15). The calculated helicity was similar among the guandinine-
containing polypleptides (52~59%) and slightly higher for the amine-containing polypeptides 
(60% and 71%). Indicated by the ellipticities at 222 nm, the helicities of all test polypeptides 
were proven to remain stable within the concentration range of 0.025-0.2 mg/mL, suggesting that 
they were well dispersed in aqueous solutions despite the hydrophobic contents on the side 
chains (Figure 14B) [24]. The helicities maintained stable within the pH range of 1-9 (Figure 
14C), enabling the polypeptides to exert their conformation-dependent membrane activities 
within a pH gradient from the neutral extracellular pH to the acidic endocytic compartments pH 
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(endosomes and lysosomes). As such, polypeptides with such helical stability would be capable 
of facilitating intracellular internalization as well as endosomal escape of the gene cargo by 
destabilizing/disrupting the cellular/endosomal membranes [26]. The helicities were also stable 
against ionic strength up to 0.3 M (Figure 14D), indicating that the helical conformations would 
be well maintained for all test polypeptides under physiological conditions with the ionic 
strength of approximately 0.15 M. 
 
3.2. Polyplex formation and characterization 
DNA condensation by the polypeptides was characterized by the gel retardation assay 
(Figure 16A). All the polypeptides were able to effectively condense DNA even at the N/P ratio 
of 2, indicated by the restricted DNA migration in the gel electrophoresis. In consistence, a 
quantitative EB exclusion assay further demonstrated that more than 70% of the DNA was 
condensed by the polypeptides at N/P rations higher than 5 (Figure 16B). Guanidine-containing 
polypeptides displayed slightly higher affinity for DNA than their amine-containing analogues, 
presumably because guanidine residues could form bidentate hydrogen bonding with phosphates 
on DNA molecules to render additional binding affinities [39]. The particle size and zeta 
potential of the formed polyplexes were further characterized by DLS. As shown in Figure 17, 
all the polypeptides were able to form 100~200 nm nanocomplexes with DNA in water at the 
N/P ratio higher than 5 with positive charges on surfaces. The polyplexes formed by guanidine-
containing polypeptides displayed higher zeta potentials (~40 mV) than those formed by amine-
containing polypeptides (~25 mV), probably because of the higher pKa value of guanidine 
groups. Polyplexes were also prepared and characterized in buffer solution (0.2 M PBS) to test 
their stability under physiological conditions. Higher N/P ratio up to 20 was required to form 
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stable polyplexes with comparable particle size (except T3), which was largely attributed to the 
charge screening effect induced by the excessive ions in the buffer solution that decrease the 
electrostatic attractions between the positively charged polypeptides and negatively charged 
DNA (Figure 17C). When polyplexes prepared in PBS were further diluted with PBS for 50 
folds, the particle size remained relatively unaltered within 1.5 h, suggesting the desired stability 
of polyplexes against ionic strength and dilution (Figure 17D). 
 
3.3. In vitro gene transfection 
The transfection efficiencies of polypeptides containing different side charged groups yet 
the fixed side chain length (P3, T3, G3) were first evaluated in HeLa and COS-7 cells in serum-
free medium. As shown in Figure 18, the polypeptide bearing guanidine groups exhibited 
significantly higher transfection efficiency than its amine-containing counterparts, suggesting 
that the guanidine groups were crucial in terms of mediating effective gene transfection 
presumably due to their membrane activities. G3 showed notably higher transfection efficiency 
by nearly two orders of magnitude than PLR adopting random coil conformation, which further 
highlighted the importance of helicity. The hydrophobic moieties can “self-activate” the 
membrane activities of guanidine groups, and thus we compared the transfection efficiencies of 
polypeptides bearing guanidine side charged groups yet different side chain length (G3, G6, G8). 
As shown in Figure 19A and 19B, in both cell lines, polypeptides with longer hydrophobic side 
chains exhibited higher transfection efficiencies at low N/P ratios (2.5 and 5), which confirmed 
the design strategy to enhance the gene delivery capacities of cationic helical polypeptides by 
introducing extra hydrophobic contents. When the N/P ratio was further elevated to 10 and 15, 
G6 demonstrated maximal transfection efficiency among those three polypeptides in HeLa cells 
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while G6 and G8 showed comparably high transfection efficiencies in COS-7 cells. The 
transfection efficiency decreased rather than kept increasing when the N/P ratio was increased up 
to 20, mainly due to the material-induced cytotoxicity at higher dosages. Polypeptides bearing 
primary amine groups yet different side chain length were also synthesized and tested in gene 
transfections. However, they all suffered from relatively low efficiencies although the increment 
in the transfection efficiency with the elongated side chains was also observed (Figure 20). With 
the collective effect of both guanidine and hydrophobic domains, G6 and G8 outperformed the 
commercial transfection reagent, LPF2000, by 2.5~5.5 folds in terms of the in vitro transfection 
efficiency (Figure 19A, 19B).  
Since serum has been reported to inhibit the efficiencies of polycation based non-viral 
gene delivery vectors [40], transfections were thus performed in the presence of serum (10%FBS) 
as well. At the same DNA amount (0.1 µg/well) and N/P ratio, greatly compromised gene 
transfection efficiency was noted for all test polypeptides (Figure 19C, 19D), presumably 
because the anionic proteins in the serum would destabilize the polyplexes. However, the 
transfection efficiency can be largely recovered when the total amount of DNA or the N/P ratio 
was increased, indicating that excessive amount of polypeptides might counteract serum binding. 
G8 showed higher resistance against serum than G3 and G6 at lower DNA amount (0.1 µg/well), 
probably because the extra hydrophobicity mediated stronger interactions between the 
polypeptides and DNA, thus partially compensating the competitive replacement by serum. 
When the DNA amount was increased to 0.2 µg/well, G6 reached maximal transfection 
efficiencies in HeLa cells while G6 and G8 were equally competent in COS-7 cells, similar to 
the transfection capacities in the absence of serum. 
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3.4. Intracellular kinetics 
The performance of non-viral gene delivery vectors is closely connected to their 
intracellular kinetics, such as the cellular uptake level, internalization pathway and endosomal 
escape mechanism [41]. We therefore probed the intracellular kinetics of the polypeptide/DNA 
polyplexes in attempts to provide mechanistic understandings on their gene delivery capacities. 
As shown in Figure 21, all test polypeptides were able to remarkably promote the 
cellular uptake of YOYO-1-DNA, outperforming LPF2000 by 4-8 folds. Polypeptides bearing 
guanidine and primary amine side charged groups (G3 and P3) displayed comparable cellular 
uptake level which was higher than that of the tertiary amine-containing polypeptide (T3). 
Notable increase in the cellular uptake level was also observed when the hydrophobic side chain 
was elongated (G3, G6, G8), which suggested that hydrophobic content activated the guanidine 
groups to provide the polypeptides with higher membrane activities. 
The internalization pathway determines the intracellular fate and ultimately affects the 
gene transfection capabilities of non-viral gene delivery vectors, and guanidine-rich CPPs have 
also been reported to promote the cellular internalization through a non-endocytic, direct 
translocation pathway [30, 42]. As such, cellular uptake studies were performed under various 
conditions that are known to inhibit specific uptake pathway in order to elucidate the 
internalization mechanism. Energy-dependent endocytosis was completely blocked at low 
temperature (4 oC) [43]. Chlorpromazine inhibited clathrin-mediated endocytosis (CME) by 
inducing the dissociation of the clathrin lattice; mβCD inhibited caveolae by depleting 
cholesterol; wortmannin inhibited macropinocytosis by inhibiting phosphatidyl inositol-3-
phosphate [41]. As shown in Figure 22A, the cellular uptake level at 4 oC was only inhibited by 
30% compared to that at 37 oC, suggesting that majority of the formed polyplexes entered cells 
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via an energy-independent and non-endocytosis pathway. In terms of those energy-dependent 
processes, mβCD induced the strongest inhibition on the cellular uptake level (~40%) while 
chlorpromazine and wortmannin only exhibited slight inhibitory effects, indicating that the 
polyplexes were internalized mainly through caveolae rather than CME and macropinocytosis. 
Compared to CME, caveolae is a non-acidic and non-digestive route of internalization, and 
therefore cargos in the caveosomes can be directly transported to the Golgi and/or endoplasmic 
reticulum [41]. Thereby, they would not undergo endosomal entrapment and lysosomal 
degradation, which largely contributed to the relatively high gene transfection efficiencies of the 
guanidine-containing helical polypeptides. Such statement was also supported by CLSM imaging, 
which was utilized to visualize the intracellular distributions of polyplexes, with polypeptide G6 
in HeLa cells as example. The internalized polyplexes (green fluorescence) were largely 
separated from the Lysotracker-stained endosomes/lysosomes (red fluorescence, Figure 22E), 
indicating that they did not experience severe endosomal entrapment which posed as one of the 
major intracellular barriers against efficient gene delivery [44]. In consistence with the 
internalization mechanism, transfection efficiency at 4 oC was still relatively high, despite the 
notable decrease compared to that at 37 oC (Figure 22B).  
Because a large amount of the polyplexes was internalized via direct translocation rather 
than endocytosis, the ability of the polypeptides to cause pore formation on cell membranes was 
then investigated, an important membrane penetration mechanism induced by the helical 
polypeptide [26, 37, 45, 46]. FITC-Tris, a membrane-impermeable fluorescent dye in the non-
reactive form of FITC after reaction of FITC with Tris [36], was used as a biomarker, and the 
pore formation level on cell membranes was monitored by the cellular uptake level of FITC-Tris 
after co-incubation with the polypeptides. Free FITC-Tris was minimally internalized by cells, 
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however, treatment with the polypeptides led to substantial increase in cellular uptake of FITC-
Tris (Figure 22C, 22D), substantiating that the guanidine-containing helical polypeptides were 
able to destabilize cell membranes by pore formation mechanism and subsequently allow the 
direct diffusion of FITC-Tris into the cytoplasm. Such pore formation capacities were further 
enhanced with the increment of hydrophobic contents. In comparison, the random-coiled PLR 
and other short CPPs including HIV-TAT and Arg9, demonstrated significantly lower pore 
formation properties. Such pore formation mechanism of polypeptides thus allowed direct 
permeation of the gene cargos into cells, and accordingly internalized YOYO-1-DNA was 
distributed to the whole cytoplasm in a permeated manner without being entrapped in 
endosomal/lysosomal compartments as shown in CLSM images (Figure 22E). 
 
3.5. Cytotoxicity 
Cytotoxicity of the polypeptide/DNA polyplexes (N/P = 10) at different DNA 
concentrations were assessed in both HeLa and COS-7 cells by the MTT assay. As shown in 
Figure 23, the cytotoxicity was both dose- and cell line-dependent. Guanidine-containing 
polypeptides displayed higher cytotoxicity than the amine-containing ones, and the polypeptides 
with longer side chains showed higher cytotoxicity in both cell lines, which correlated well with 
their pore formation capabilities. For each individual polypeptide, its toxicity towards HeLa cells 
was higher than towards COS-7 cells, presumably due to the different tolerability of each cell 
line towards material-induced cytotoxicity. 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
Non-viral gene delivery vectors have emerged as promising alternatives to viral vectors 
due to their accessibility and safety profile. However, the major drawback of non-viral gene 
delivery is low transfection efficiency, stemming from multiple extra- and intracellular barriers 
associated with delivery process [44]. Above all, vectors should be able to effectively condense 
DNA into nano-scale complexes, maintain relatively stable under physiological conditions and 
then mediate efficient cellular uptake either via endocytosis or non-endocytic pathway. Among 
the existing polymer-based materials adopted as non-viral vectors, most of them possess cationic 
amine groups that could be protonated under physiological conditions and then could condense 
DNA to form polyplexes, such as poly(ethylenimine) (PEI), PLL and poly(amidoamine) 
dendrimer (PAMAM). Further modifications/conjugations, exemplified by modification with 
targeting moieties and PEGylation, could further promote the delivery efficiency and reduce the 
material cytotoxicity induced by excessive cationic charges [47]. Studies have also shown that 
such polyplexes are often internalized via endocytosis [48, 49], which leads to the transport of 
polyplexes from early endosomes to lysosomes filled with hydrolytic enzymes. Therefore, 
endosomal entrapment poses one major barrier that impedes the efficacy of non-viral vectors. 
PEI, one of the most widely used non-viral vectors containing large amount of primary, 
secondary and tertiary amine groups, is able to buffer the acidic environment in lysosomes, cause 
extra protons being pumped into the compartments, and finally osmotically rupture the 
lysosomes by the influx of counter ions, commonly known as the “proton sponge” effect [50]. 
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However, this hypothesis has been debated and recent studies have suggested that the 
incorporation of amine groups with buffering capacity does not necessarily result in effective 
endosomal escape [51, 52]. At later stage, DNA needs to be released from complexes and 
transported from cytoplasm to the nuclei in order to initiate successful transcription. 
Compared with amine groups, guanidine groups could bind DNA phosphate anions to 
form characteristic pairs of parallel hydrogen bonds, which stabilize the binding by not only their 
charge but also their structural organization [53]. Similarly, such bidentate hydrogen bonding 
could also be formed between guanidine groups and negatively charged carboxylates, sulfates 
and phosphates on cell surface. The resultant ion-pairs could then translocate across the cell 
membrane due to the influence of the membrane potential, which is a different pathway from 
conventional endocytosis [39, 54]. Although multiple mechanisms have been proposed and no 
universal mechanism has been agreed on, such membrane activity of guanidine groups has been 
reported to enable efficient cellular uptake and endosomal escape of various cargos by 
destabilizing the cellular as well as endosomal membranes [55]. Herein, we incorporated 
guanidine groups into our rational design of helical polypeptide-based non-viral vectors, and 
compared the gene delivery efficiencies with their amine-containing counterparts. G3 
demonstrated much higher gene transfection efficiency than P3 and T3, despite their comparable 
DNA binding strength and cellular uptake level (Figure 21). Intracellular kinetics studies further 
suggested that G3, G6 and G8 were internalized mainly through energy-independent permeation 
or caveolae-mediated endocytosis, which both avoid endosomal entrapment. We speculated that 
such effective pathways of cell entry largely contributed to the excellent gene transfection 
efficiencies of the guanidine-containing polypeptides. 
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In addition to guanidine group, secondary structure and hydrophobicity also have impact 
on the membrane activities of CPPs. Therefore, we hypothesized that the inclusion of helical 
structures and hydrophobic content could alter the membrane activities of polypeptides and 
ultimately affect their gene delivery efficiencies. In comparison to PLR which adopts random 
coil conformation and lacks hydrophobicity, G3 possessed long hydrophobic side chains and 
thus was able to adopt helical conformation because the electrostatic interactions among pendant 
charged groups was greatly decreased. The notably enhanced pore formation properties and gene 
transfection efficiencies collectively substantiated the importance of the introduced helical 
structure and hydrophobicity. Moreover, our previous studies on the comparison of cationic 
polypeptides with exactly the same chemical composition yet different secondary structure (helix 
vs. random coil) also revealed that helical structure remarkably contributed to the strong pore 
formation properties of polypeptides to mediate effective gene transfection [26, 45]. Further 
increasing the hydrophobicity by elongating the side chain resulted in further elevated pore 
formation activities. As a result, G8 was able to mediate effective transfection efficiencies at the 
N/P ratio of 5 while comparable efficiencies were noted at the N/P ratio of 10 for G3 and G6 
(Figure 19A, 19B). In consistence, G6 and G8 showed notably higher resistance against serum 
than G3, a desired property towards in vivo gene delivery. 
The pore formation mechanism, although highly effective in triggering cellular 
internalization and endosomal escape, will at the same cause irreversible damage to the cell 
membranes at excessive levels. This holds true for guanidine-containing helical polypeptides, 
where longer hydrophobic side chain length rendered the polypeptides with higher membrane 
activities but also higher cytotoxicities. Consequently, in HeLa cells which are more vulnerable 
to material-induced cytotoxicity, G8 displayed decreased rather than increased gene transfection 
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efficiency compared to G6 due to the comprised cell viability. COS-7cells were more resistant to 
material-induced cytotoxicity, and therefore G6 and G8 were equally efficient in COS-7 cells. 
Serum could shield the surface charge of the polyplexes to reduce material cytotoxicity [56], and 
therefore at the same DNA amount, G8 with the highest membrane activity revealed the highest 
transfection efficiency. At higher DNA amount (0.2 µg/well), excessive G8 displayed 
appreciable cytotoxicities and thus the transfection efficiency remained slightly lower than G6, 
the same trend as observed under serum-free condition. These results collectively suggest that an 
optimal balance between membrane activity and cytotoxicity is crucial towards the maximization 
of the gene delivery efficiencies of helical polypeptides and other polycation-based non-viral 
vectors.
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CHAPTER 5 
 
 
CONCLUSION 
 
 
By taking advantage of well-controlled HMDS-mediated ROP of NCA and highly 
efficient “click” chemistry, a set of α-helical, cationic polypeptides with diverse charged groups 
as well as hydrophobic side chain lengths were synthesized and systematically investigated in 
terms of the effect of polypeptide structure on the gene delivery efficiencies. Incorporation of 
guanidine group, helical conformation and hydrophobic content into the polypeptide-based non-
viral vectors collectively led to materials with high membrane activities and transfection 
efficiencies, outperforming LPF2000 by 2.5~5.5 folds. Although hydrophobicity enhanced the 
membrane activities of the polypeptides via the pore formation mechanism, excessive 
hydrophobicity will simultaneously cause irreversible damage to cell membranes and ultimately 
impair the transfection efficiencies. Therefore, a proper balance between membrane activities 
and cytotoxicities needs to be determined during the material design in order to maximize the 
efficacy of non-viral vectors. Such study on structure-function relations provides insights into the 
rational design of non-viral vectors and the top-performing materials identified (G6 and G8) may 
serve as promising additions to the existing vectors. 
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FIGURES AND TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Structures of amine/guanidine functionalized polypeptides. 
 
Polypeptide m R 
Helicity  
(%) 
G3 3 
 
52 
G6 6 
 
59 
G8 8 
 
55 
P3 3 
 
60 
T3 3 
 
71 
28 
 
 
 
 
 
Figure 1. Synthetic routes of γ-(4-propargyloxybenzyl)-L-glutamic acid based N-
carboxyanhydride (POB-L-Glu-NCA). 
 
 
 
Figure 2. Synthetic routes of azido amines/guanidines. 
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Figure 3. Synthetic route of amine/guanidine functionalized polypeptides. 
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Figure 4. GPC trace of poly(γ-(4-propargyloxybenzyl)-L-glutamate) (PPOBLG). 
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Figure 5. 1H NMR spectrum of POB-L-Glu-NCA in CDCl3. 
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Figure 6. 1H NMR spectrum of PPOBLG in CDCl3. 
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Figure 7. 1H NMR spectrum of polypeptide G3 in TFA-d. 
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Figure 8. 1H NMR spectrum of polypeptide G6 in TFA-d. 
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Figure 9. 1H NMR spectrum of polypeptide G8 in TFA-d. 
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Figure 10. 1H NMR spectrum of polypeptide P3 in TFA-d. 
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Figure 11. 1H NMR spectrum of polypeptide P5 in TFA-d. 
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Figure 12. 1H NMR spectrum of polypeptide P8 in TFA-d. 
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Figure 13. 1H NMR spectrum of polypeptide T3 in TFA-d. 
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Figure 14. (A) CD spectra of polypeptides (0.1 mg/mL) in the aqueous solution (pH 7.0). 
Helical stability against polypeptide concentration (B), pH (C) and NaCl concentration 
(D) as indicated by the molar ellipticity at 222 nm. 
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Figure 15. CD spectrum of PLR in water (0.1 mg/mL) at pH 7.
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Figure 16. DNA condensation by polypeptides at various N/P ratios as evaluated by the gel 
retardation assay (A) and EB exclusion assay (B). N represents naked DNA. 
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Figure 17. Particle size (A) and zeta potential (B) of polyplexes in DI water at various N/P ratios 
as determined by DLS measurement. (C) Particle size of polyplexes at various N/P ratios 
prepared in PBS. (D) Alteration of particle size of polyplexes (N/P = 20, prepared in PBS) upon 
dilution with PBS (x 50 fold). 
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Figure 18. In vitro transfection efficiencies of polyplexes (N/P = 10) in HeLa (A) and COS-7 (B) 
cells. PLR and LPF2000 were included as positive controls. 
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Figure 19. In vitro transfection efficiencies of polyplexes at various N/P ratios in HeLa (A) and 
COS-7 (B) cells in the serum-free medium. Transfection efficiencies in HeLa (C) and COS-7 (D) 
cells in the presence of serum. 
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Figure 20. In vitro transfection efficiencies of polyplexes at various N/P ratios in HeLa cells. 
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Figure 21. Cellular uptake levels of polypeptide/YOYO-1-DNA polyplexes in HeLa (A) and 
COS-7 (B) cells at various N/P ratios. 
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Figure 22. Intracellular kinetics of polypeptide/YOYO-1-DNA polyplexes. (A) Cellular uptake 
of polyplexes (N/P = 10) in COS-7 cells at 4 °C or in the presence of various endocytic inhibitors. 
(B) Transfection efficiencies of polyplexes (N/P = 10) at 4 °C and 37 °C in COS-7 cells. (C) Cell 
uptake level of FITC-Tris in HeLa (C) and COS-7 (D) cells following co-incubation with the 
polypeptides for 2 h at 37 °C. (E) CLSM images of HeLa cells following incubation with 
G6/YOYO-1-DNA polyplexes (N/P = 10) at 37 °C for 4 h. Bar represented 20 µm. 
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Figure 23. Cytotoxicity of polyplexes (N/P = 10) towards HeLa (A) and COS-7 (B) cells as 
determined by the MTT assay.
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